<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Human herpesvirus 6 infection in children: Clinical manifestations, diagnosis, and treatment
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Human herpesvirus 6 infection in children: Clinical manifestations, diagnosis, and treatment
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Human herpesvirus 6 infection in children: Clinical manifestations, diagnosis, and treatment
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Cécile Tremblay, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael T Brady, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sheldon L Kaplan, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Diane Blake, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 08, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical manifestations, diagnosis, and treatment of human herpesvirus 6 (HHV-6) infection in children will be discussed here. Roseola and the virology, pathogenesis, and epidemiology of HHV-6, the clinical manifestations, diagnosis, and treatment of HHV-6 infections in adults, and HHV-6 infection in hematopoietic cell transplant recipients are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6035.html" rel="external">
          "Roseola infantum (exanthem subitum)"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/8302.html" rel="external">
          "Virology, pathogenesis, and epidemiology of human herpesvirus 6 infection"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/8320.html" rel="external">
          "Clinical manifestations, diagnosis, and treatment of human herpesvirus 6 infection in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/16146.html" rel="external">
          "Human herpesvirus 6 infection in hematopoietic cell transplant recipients"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H430627055">
         <span class="h1">
          VIROLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         HHV-6 is a member of the
         <em>
          Herpesviridae
         </em>
         family. HHV-6 replicates in activated CD4+ T lymphocytes [
         <a href="#rid1">
          1
         </a>
         ]. There are two HHV-6 species: HHV-6A and HHV-6B. HHV-6B causes the majority of documented primary infections and reactivations events. Little is known about the epidemiology or clinical implications of HHV-6A. (See
         <a class="medical medical_review" href="/z/d/html/8302.html" rel="external">
          "Virology, pathogenesis, and epidemiology of human herpesvirus 6 infection", section on 'Virology and pathogenesis'
         </a>
         .)
        </p>
        <p>
         Like other herpesviruses, HHV-6 establishes latency after primary infection and may reactivate in immunocompromised hosts, especially after allogeneic hematopoietic cell transplantation. (See
         <a class="medical medical_review" href="/z/d/html/16146.html" rel="external">
          "Human herpesvirus 6 infection in hematopoietic cell transplant recipients"
         </a>
         .)
        </p>
        <p>
         Latency of HHV-6 usually occurs through integration into the telomeric region of a human chromosome as a result of homologous recombination, typically in a small proportion of somatic cells [
         <a href="#rid2">
          2
         </a>
         ]. However, integration into germline cells is responsible for congenital HHV-6 infections [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1786231983">
         <span class="h1">
          EPIDEMIOLOGY AND TRANSMISSION
         </span>
         <span class="headingEndMark">
          —
         </span>
         HHV-6 infects most children within the first two years of life [
         <a href="#rid4">
          4,5
         </a>
         ], but rarely may be acquired in adulthood [
         <a href="#rid6">
          6
         </a>
         ]. In developed countries, the rate of seroprevalence among adults is generally &gt;70 percent. (See
         <a class="medical medical_review" href="/z/d/html/8302.html" rel="external">
          "Virology, pathogenesis, and epidemiology of human herpesvirus 6 infection", section on 'Epidemiology'
         </a>
         .)
        </p>
        <p>
         Although there are few data regarding the incubation period of HHV-6 infection, it is thought to be approximately nine days (range 5 to 15 days) [
         <a href="#rid7">
          7,8
         </a>
         ].
        </p>
        <p>
         Transmission may occur:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prenatally – Prenatal transmission generally occurs through germline transmission of chromosomally integrated HHV-6 from either parent [
         <a href="#rid3">
          3,9
         </a>
         ]. In utero transmission of reactivated virus or primary infection (ie, initial infection or infection with a new strain) occurs rarely. (See
         <a class="local">
          'Congenital infection'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postnatally – Postnatal transmission occurs mainly through saliva. Transmission through breast milk or blood products has not been reported [
         <a href="#rid10">
          10
         </a>
         ]. Transmission through organ or hematopoietic cell donation has been reported rarely [
         <a href="#rid11">
          11-14
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         In approximately 1 percent of people, HHV-6 DNA is integrated into chromosomes, including chromosomes in germline cells [
         <a href="#rid15">
          15
         </a>
         ]. Children born to individuals with chromosomally integrated HHV-6 can have one copy of virus per nucleated cell [
         <a href="#rid16">
          16-18
         </a>
         ]. When an individual with chromosomally integrated HHV-6 donates hematopoietic stem cells, the transplant recipient will have integrated virus in their nucleated hematopoietic cells.
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical manifestations of HHV-6 infection vary with the age and immune competence of the child.
        </p>
        <p class="headingAnchor" id="H1725477875">
         <span class="h2">
          Congenital infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Congenital HHV-6 infection occurs in approximately 1 percent of newborn infants [
         <a href="#rid3">
          3,19,20
         </a>
         ]. Most congenital infections with HHV-6 are asymptomatic. However, subtle neurodevelopmental effects may occur [
         <a href="#rid21">
          21
         </a>
         ]. Although congenital HHV-6 has been associated with more severe manifestations (eg, respiratory failure, cardiac and gastrointestinal anomalies), the causal role of HHV-6 could not be determined [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2435695078">
         <span class="h2">
          Immunocompetent children
         </span>
         <span class="headingEndMark">
          —
         </span>
         The classic manifestations of primary HHV-6 infection in immunocompetent children are roseola infantum (also known as exanthem subitum and sixth disease) and acute febrile illnesses with or without a rash. Other nonspecific symptoms, such as fussiness and rhinorrhea, can occur with primary infection in the absence of fever [
         <a href="#rid4">
          4
         </a>
         ]. Other clinical syndromes (eg, hepatitis, myocarditis, encephalitis) may occur, sometimes in the setting of coinfection with another viral illness [
         <a href="#rid23">
          23,24
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h3">
          Acute febrile illness
         </span>
         <span class="headingEndMark">
          —
         </span>
         Primary HHV-6 infection often presents as a febrile illness without a rash [
         <a href="#rid4">
          4,5,25-28
         </a>
         ]. In a prospective study of 81 children with well-defined onset of primary HHV-6 infection, fever (57 percent), fussiness (69 percent), and rhinorrhea (65 percent) were the most frequent manifestations [
         <a href="#rid4">
          4
         </a>
         ]. Cough, diarrhea, and rash occurred in a minority of children. In another prospective study of 160 children who presented to the emergency department for acute febrile illness and were found to have primary HHV-6 infection, the mean temperature at the time of presentation was 39.6°C (103.3°F), compared with 38.9°C (102.0°F) in children without HHV-6 [
         <a href="#rid5">
          5
         </a>
         ]. Fever was most commonly accompanied by irritability, otitis media, upper and lower respiratory symptoms, or diarrhea. Seizures occurred in 13 percent.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Febrile seizures
         </strong>
         – HHV-6 infection has been associated with febrile seizures [
         <a href="#rid5">
          5,29-31
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6183.html" rel="external">
          "Clinical features and evaluation of febrile seizures", section on 'Infection'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H486366141">
         <span class="h3">
          Roseola infantum
         </span>
         <span class="headingEndMark">
          —
         </span>
         HHV-6 is the most frequent cause of roseola infantum (exanthem subitum, also called roseola or sixth disease). Roseola is characterized by three to five days of high fever that resolves abruptly and is followed by development of a rash  (
         <a class="graphic graphic_picture graphicRef81967" href="/z/d/graphic/81967.html" rel="external">
          picture 1
         </a>
         ). Approximately 25 to 30 percent of children with primary HHV-6 infection develop roseola [
         <a href="#rid4">
          4,32
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6035.html" rel="external">
          "Roseola infantum (exanthem subitum)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3924896659">
         <span class="h3">
          Less common manifestations
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Meningoencephalitis
         </strong>
         – Encephalitis of variable severity can rarely occur as a complication of roseola or as the primary manifestation of HHV-6 infection in otherwise immunocompetent hosts [
         <a href="#rid33">
          33-38
         </a>
         ]. Panencephalitis is most common, but a focal necrotic encephalitis mimicking herpes simplex virus encephalitis has been reported [
         <a href="#rid33">
          33,39
         </a>
         ]. The detection of viral antigens in neural cells suggests that the encephalitis is caused by a direct viral effect, but immune-mediators also may play a role [
         <a href="#rid40">
          40
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6042.html" rel="external">
          "Acute viral encephalitis in children: Clinical manifestations and diagnosis", section on 'Clinical features'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mesial temporal lobe epilepsy
         </strong>
         – HHV-6 has been associated with mesial temporal lobe epilepsy (MTLE). In pathology studies, HHV-6 DNA was recovered more frequently from brain biopsies from patients with MTLE than from patients without MTLE, suggesting that HHV-6 has pathologic effects [
         <a href="#rid41">
          41-43
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2231.html" rel="external">
          "Focal epilepsy: Causes and clinical features", section on 'Mesial temporal lobe epilepsy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mononucleosis-like syndrome
         </strong>
         – HHV-6 has also been reported in association with a mononucleosis-like syndrome in infants and adults [
         <a href="#rid6">
          6,44-46
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8320.html" rel="external">
          "Clinical manifestations, diagnosis, and treatment of human herpesvirus 6 infection in adults", section on 'Primary infection'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hepatitis
         </strong>
         – HHV-6 has also been reported in association with liver failure of unknown etiology [
         <a href="#rid47">
          47,48
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H694510971">
         <span class="h3">
          Unproven associations
         </span>
         <span class="headingEndMark">
          —
         </span>
         HHV-6 may be activated by a number of acute illnesses. In many of these clinical syndromes, it is difficult to establish HHV-6 as the causative agent. Associations between HHV-6 and the following conditions have been proposed but remain unproven:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pneumonitis [
         <a href="#rid49">
          49
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Myocarditis, cardiomyopathy, and congenital heart disease [
         <a href="#rid50">
          50-54
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Immune thrombocytopenia [
         <a href="#rid55">
          55,56
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Viral associated hemophagocytic syndrome [
         <a href="#rid57">
          57-59
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Langerhans cell histiocytosis [
         <a href="#rid60">
          60
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Papular-purpuric "gloves and socks" syndrome [
         <a href="#rid61">
          61
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gianotti-Crosti syndrome [
         <a href="#rid62">
          62
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Purpura fulminans [
         <a href="#rid63">
          63
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Guillain-Barré syndrome [
         <a href="#rid64">
          64
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Facial nerve palsy [
         <a href="#rid65">
          65,66
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Drug reaction with eosinophilia and systemic symptoms, also known as drug-induced hypersensitivity syndrome (see
         <a class="medical medical_review" href="/z/d/html/16420.html" rel="external">
          "Drug reaction with eosinophilia and systemic symptoms (DRESS)", section on 'Reactivation of Herpesviridae'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Encephalopathy, hepatitis [
         <a href="#rid67">
          67
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Immunocompromised children
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with primary or secondary cellular immune deficiencies are more likely than immunocompetent children to have clinically relevant reactivation or new infection with herpesviruses such as HHV-6. However, establishing HHV-6 as the cause in such children is problematic for several reasons, including:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Children with cellular immune deficiencies are frequently coinfected with other herpesviruses, such as cytomegalovirus (CMV), and other opportunistic infections [
         <a href="#rid68">
          68
         </a>
         ]. Rises in antibody titers often occur against several viruses simultaneously.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The high prevalence of viral DNA in peripheral blood mononuclear cells of healthy controls limits the use of qualitative polymerase chain reaction (PCR) to discriminate between latency and active infection.
        </p>
        <p>
        </p>
        <p>
         Examples of clinical manifestations HHV-6 infection in immunocompromised children include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Children with cancer
         </strong>
         – In children with lymphoma, HHV-6 has been associated with decreased white blood cell count and hemoglobin. In an observational study, herpesvirus DNA (HHV-6 or CMV) was detected by PCR in the plasma or white blood cells of children with Hodgkin or non-Hodgkin lymphoma more often than in controls (46 versus 10 percent) [
         <a href="#rid69">
          69
         </a>
         ]. Detection of both HHV-6 and CMV was associated with more frequent episodes of febrile neutropenia, absolute neutrophil count &lt;800 cells/microL, lymphocytes &lt;500 cells/microL, and hemoglobin &lt;9.1 g/dL. Detection of HHV-6 DNA was predictive of immunosuppression before the onset of CMV infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a cross-sectional study of beta-herpesviruses (HHV-6, HHV-7, and CMV) in 30 children with cancer, HHV-6B DNA was detected in the blood of four patients (13 percent) [
         <a href="#rid70">
          70
         </a>
         ]. HHV-6B DNA was associated with hepatitis in one case and mild viral illness in another. Although HHV-6B was detected less frequently in children with cancer than in a control group of children with solid organ transplants, it should be considered in the differential diagnosis of febrile children with cancer.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Transplant recipients
         </strong>
         – HHV-6 reactivation syndromes occur in approximately 50 percent of hematopoietic cell transplant (HCT) recipients and 20 to 62 percent of solid organ transplant recipients [
         <a href="#rid71">
          71,72
         </a>
         ]. Primary HHV-6 infection has also been reported among solid organ transplant recipients [
         <a href="#rid73">
          73-75
         </a>
         ]. Clinical manifestations of HHV-6 in HCT recipients are discussed in detail separately. HHV-6 encephalitis is the most clearly established clinical manifestation of HHV-6 reactivation in allogenic HCT recipients and is the most common cause of encephalitis in this population. Early recognition and empiric therapy are crucial. (See
         <a class="medical medical_review" href="/z/d/html/16146.html" rel="external">
          "Human herpesvirus 6 infection in hematopoietic cell transplant recipients", section on 'HHV-6 encephalitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Reactivation of HHV-6 usually occurs two to four weeks posttransplantation [
         <a href="#rid76">
          76
         </a>
         ]. Rarely, primary infection with HHV-6 can occur through transmission from the donor [
         <a href="#rid11">
          11-13,75
         </a>
         ]. In addition, HHV-6 may be a cofactor for CMV disease in transplant recipients [
         <a href="#rid72">
          72,77
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         HHV-6 infection has been reported in adult and pediatric transplant recipients. The majority of HHV-6 infections in transplant recipients are asymptomatic [
         <a href="#rid71">
          71
         </a>
         ]. However, the following manifestations have been described in children who have undergone HCT or solid organ transplantation:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Unexplained fever [
         <a href="#rid71">
          71,78,79
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Viremia [
         <a href="#rid76">
          76
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Rash [
         <a href="#rid13">
          13,80
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hepatitis [
         <a href="#rid12">
          12,71
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pneumonitis [
         <a href="#rid71">
          71,81,82
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Myocarditis [
         <a href="#rid83">
          83
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Encephalitis [
         <a href="#rid71">
          71,84-87
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Colitis [
         <a href="#rid88">
          88
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bone marrow suppression [
         <a href="#rid71">
          71,89,90
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Macrophage activation syndrome [
         <a href="#rid91">
          91
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Graft failure [
         <a href="#rid84">
          84
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Graft rejection [
         <a href="#rid71">
          71
         </a>
         ]
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Graft-versus-host disease (GVHD) in some [
         <a href="#rid81">
          81,92
         </a>
         ], but not all reports [
         <a href="#rid76">
          76,93
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Early reactivation of HHV-6 with high levels of HHV-6 DNAemia (ie, &gt;1000 HHV-6 DNA copies/mL) is associated with increased reactivation of CMV (which may worsen posttransplant pneumonitis), increased rates of grades II to IV acute GVHD, and increased nonrelapse mortality [
         <a href="#rid77">
          77,94,95
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16146.html" rel="external">
          "Human herpesvirus 6 infection in hematopoietic cell transplant recipients", section on 'Disease associations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H3141829635">
         <span class="h2">
          In immunocompetent children
         </span>
         <span class="headingEndMark">
          —
         </span>
         In immunocompetent children with typical presentations of HHV-6 (eg, acute illness with high fever, with or without rash, and nonspecific symptoms), laboratory confirmation of HHV-6 is seldom necessary and is unlikely to affect management. In these children, HHV-6 generally resolves spontaneously without adverse effects.
        </p>
        <p>
         A clinical diagnosis of roseola can be made in young children with the classic presentation (eg, fever for three to five days followed by abrupt defervescence and development of a rash  (
         <a class="graphic graphic_picture graphicRef81967" href="/z/d/graphic/81967.html" rel="external">
          picture 1
         </a>
         )). (See
         <a class="medical medical_review" href="/z/d/html/6035.html" rel="external">
          "Roseola infantum (exanthem subitum)", section on 'Clinical features'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2742591846">
         <span class="h2">
          Indications for laboratory confirmation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Laboratory confirmation of HHV-6 may be necessary in immunocompromised children or immunocompetent children with atypical presentations or complications (eg, meningoencephalitis). In such patients, diagnosis of HHV-6 may affect management (eg, antimicrobial therapy, immunosuppressive therapy) or facilitate monitoring of the clinical course and/or therapy [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="local">
          'Treatment'
         </a>
         below.)
        </p>
        <p>
         The diagnosis of HHV-6 encephalitis in hematopoietic cell transplant recipients is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/16146.html" rel="external">
          "Human herpesvirus 6 infection in hematopoietic cell transplant recipients", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H281465548">
         <span class="h2">
          Approach to laboratory testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Confirmation of HHV-6 as a causative pathogen is complicated by the high seroprevalence of HHV-6 in individuals older than three years, the persistence of HHV-6 DNA after primary infection  (
         <a class="graphic graphic_figure graphicRef57693" href="/z/d/graphic/57693.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid5">
          5
         </a>
         ], and the possibility of integration of HHV-6 DNA into chromosomes (in approximately 1 percent of the population). In addition, reactivation of HHV-6 may occur in healthy children without apparent illness [
         <a href="#rid96">
          96
         </a>
         ]. Available microbiologic methods can establish the presence of replicating HHV-6, but not causality or the timing of infection (eg, acute versus reactivation, versus reinfection)  (
         <a class="graphic graphic_table graphicRef83219" href="/z/d/graphic/83219.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         Confirmation that an illness is caused by HHV-6 typically requires a compatible clinical syndrome, evidence of active HHV-6 infection (ie, with viral replication), and elimination of other conditions in the differential diagnosis [
         <a href="#rid97">
          97,98
         </a>
         ]. A combination of laboratory tests may be necessary [
         <a href="#rid99">
          99
         </a>
         ]. Consultation with an expert in infectious diseases is suggested. (See
         <a class="local">
          'Exclusion of other conditions'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3021184490">
         <span class="h3">
          Compatible clinical features
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinical features that are compatible with active HHV-6 infection include [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A predisposing condition (eg, defect in cellular immunity)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dynamics of viral replication or serologic response (if obtained) that follow the clinical course
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Clinical findings that correspond to HHV-6 tropism, particularly in immunocompetent children (eg, viremia, encephalitis)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         No evidence of other pathogens known to cause the clinical syndrome (eg, herpes simplex virus in children with encephalitis) (see
         <a class="local">
          'Exclusion of other conditions'
         </a>
         below)
        </p>
        <p>
        </p>
        <p>
         Compatible clinical features help to differentiate HHV-6 infection from incidental detection of HHV-6 (eg, latent infection or asymptomatic reactivation) given the high seroprevalence of HHV-6 in individuals &gt;3 years of age and the persistence of HHV-6 after primary infection  (
         <a class="graphic graphic_figure graphicRef57693" href="/z/d/graphic/57693.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         Compatible clinical features also help differentiate HHV-6 infection from HHV-6 detection due to integration of HHV-6 DNA into chromosomes (in approximately 1 percent of the population).
        </p>
        <p class="headingAnchor" id="H2086028064">
         <span class="h3">
          Evidence of HHV-6 infection with viral replication
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of tests can be used to provide evidence of HHV-6 infection and replication  (
         <a class="graphic graphic_table graphicRef83219" href="/z/d/graphic/83219.html" rel="external">
          table 1
         </a>
         ), and may help to determine the timing of infection. A combination of laboratory tests may be necessary [
         <a href="#rid99">
          99
         </a>
         ]. Viral replication indicates active infection (primary infection or reactivation) [
         <a href="#rid1">
          1,100
         </a>
         ]. Viral replication in patients with negative serology suggests primary infection rather than reactivation.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Quantitative real-time HHV-6 PCR
         </strong>
         – Among the available tests, quantitative real-time HHV-6 polymerase chain reaction (PCR) provides the most useful information  (
         <a class="graphic graphic_table graphicRef83219" href="/z/d/graphic/83219.html" rel="external">
          table 1
         </a>
         ). Quantitative real-time HHV-6 PCR may be performed on any tissue; it is typically performed on whole blood, serum, plasma, and cerebrospinal fluid (CSF). It is highly sensitive and specific and permits HHV-6 speciation. High HHV-6 viral load in the CSF supports HHV-6 as the causative pathogen, particularly in an immunocompromised child [
         <a href="#rid101">
          101
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Quantitative PCR of whole blood, as well as plasma, serum and peripheral mononuclear cells, may facilitate preliminary categorization of infection according to levels of HHV-6 DNA [
         <a href="#rid1">
          1,102-106
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Latent: Low levels
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Active: Intermediate levels
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Chromosomally integrated HHV-6: High levels (typically &gt;1 million copies/mL)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         These categorizations are only preliminary because quantitative thresholds for "low," "intermediate," and "high," and a specific threshold for active versus chromosomally integrated HHV-6 infection, have not been established [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Reverse transcriptase and droplet digital PCR
         </strong>
         – For patients with intermediate or high levels of HHV-6 DNA, additional PCR techniques may be helpful in distinguishing latent from active infection or diagnosing chromosomally integrated HHV-6 DNA:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Reverse transcriptase PCR – In research laboratories, for patients with intermediate or high levels of HHV-6 DNA, positive reverse transcriptase PCR (RT-PCR), which detects HHV6-mRNA, indicates active infection  (
         <a class="graphic graphic_table graphicRef83219" href="/z/d/graphic/83219.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid99">
          99,100
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         RT-PCR can be performed on blood and plasma. In addition, a multiplex RT-PCR microarray including seven neurotropic viruses (eg, HHV-6, herpesviruses, human enteroviruses) is commercially available for central nervous system viral infection detection in CSF [
         <a href="#rid107">
          107
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Droplet digital PCR – Droplet digital PCR, which provides precise quantitation of the ratio of HHV-6 to cellular DNA, can be used to identify chromosomally integrated HHV-6 [
         <a href="#rid108">
          108
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Qualitative HHV-6 PCR
         </strong>
         – Qualitative real-time HHV-6 PCR may be performed on any tissue; it is typically performed on whole blood, serum, plasma, and CSF. It is sensitive and specific and permits HHV-6 speciation. However, it does not differentiate between latent infection, active infection, and chromosomally integrated DNA [
         <a href="#rid1">
          1,46,97,109-112
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <strong>
          The availability of multiplex PCR
         </strong>
         -based tests has enhanced identification of causative agents for meningitis and encephalitis. However, detection of HHV-6 with multiplex PCR-based tests is not sufficient evidence of causation. In an immunocompetent child, particularly if there is credible evidence of an alternate diagnosis for the neurologic findings, detection of HHV-6 more commonly represents viral latency, asymptomatic reactivation, or chromosomal integration than HHV-6 meningitis or encephalitis (given that HHV-6 infections are common and occur early in life) [
         <a href="#rid97">
          97,113
         </a>
         ]. (See
         <a class="local">
          'Exclusion of other conditions'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Viral culture
         </strong>
         – Viral culture may be performed on peripheral blood mononuclear cells, CSF, and a variety of tissues. A positive viral culture indicates replication and permits HHV-6 speciation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Viral culture is not always available and is limited by its low sensitivity, technical difficulty, and long turn-around time [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antigen detection
         </strong>
         – Monoclonal antibodies against specific HHV-6A and HHV-6B antigens, as well as a polyclonal antibody against HHV-6 U90 protein, indicate viral replication and permit HHV-6 detection and speciation in blood and tissue [
         <a href="#rid114">
          114-116
         </a>
         ]. However, antigen detection is not standardized and has limited sensitivity [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Serology
         </strong>
         – Serologic tests for the detection of HHV-6 IgG antibody include indirect immunofluorescence assays, anticomplement immunofluorescence, competitive radioimmunoassay, and neutralization and enzyme immunoassays [
         <a href="#rid117">
          117-119
         </a>
         ]. The sensitivity of these assays varies. Serologic assays do not distinguish between the HHV-6A and HHV-6B variants and cross-react with other beta-herpesviruses (eg, HHV-7 and cytomegalovirus [CMV]).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Because most people ≥2 years of age are seropositive for HHV-6  (
         <a class="graphic graphic_figure graphicRef57693" href="/z/d/graphic/57693.html" rel="external">
          figure 1
         </a>
         ), a single positive result cannot be interpreted. Paired sera need to be collected, with a ≥4-fold rise in titers considered diagnostic [
         <a href="#rid120">
          120
         </a>
         ]. Seroconversion from negative to positive is good evidence of primary infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         HHV-6 immunoglobulin M (IgM) develops within four to seven days of infection. However, many culture-positive children do not develop detectable IgM responses, and approximately 5 percent of healthy adults are IgM positive at any given time, making this test unreliable for a definitive diagnosis of active disease [
         <a href="#rid121">
          121
         </a>
         ]. The mu-capture immunoassay appears to perform more accurately than older generation assays and does not cross react with Epstein-Barr virus or CMV IgM-positive sera [
         <a href="#rid122">
          122
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2244134105">
         <span class="h3">
          Exclusion of other conditions
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of HHV-6 infection depends upon the clinical presentation and immunocompetence of the host:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute febrile illness
         </strong>
         – The differential diagnosis of acute febrile illness with nonspecific symptoms in an immunocompetent child includes other common childhood illnesses. Given that the illness usually resolves spontaneously within a few days, it generally is not necessary to identify the specific pathogen. The evaluation of fever in young children is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6075.html" rel="external">
          "Fever without a source in children 3 to 36 months of age: Evaluation and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fever and rash (roseola)
         </strong>
         – The differential diagnosis of roseola includes other infectious exanthems and drug allergy  (
         <a class="graphic graphic_figure graphicRef104587" href="/z/d/graphic/104587.html" rel="external">
          figure 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/6035.html" rel="external">
          "Roseola infantum (exanthem subitum)", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Febrile seizure
         </strong>
         – The differential diagnosis of febrile seizure includes nonepileptic events or movements, provoked seizures from central nervous system infection (eg, meningitis or encephalitis), and rare forms of genetic epilepsy in which seizures are particularly common with fever. (See
         <a class="medical medical_review" href="/z/d/html/6183.html" rel="external">
          "Clinical features and evaluation of febrile seizures", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Meningoencephalitis
         </strong>
         – The differential diagnosis of meningoencephalitis in immunocompetent children includes other central nervous system infections, postinfectious encephalitis, autoimmune encephalitis, toxic metabolic conditions, and noninfectious intracranial pathology.
         <strong>
         </strong>
         (See
         <a class="medical medical_review" href="/z/d/html/6042.html" rel="external">
          "Acute viral encephalitis in children: Clinical manifestations and diagnosis", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          TREATMENT
         </span>
        </p>
        <p class="headingAnchor" id="H149491016">
         <span class="h2">
          Indications
         </span>
         <span class="headingEndMark">
          —
         </span>
         In immunocompetent children, HHV-6 infection usually is a benign disease that resolves spontaneously and does not require specific therapy.
        </p>
        <p>
         Antiviral therapy may be warranted for HHV-6 infections associated with increased morbidity (eg, encephalitis, myocarditis) in both immunocompetent and immunocompromised hosts, although efficacy data are limited and no controlled trials have been reported. If feasible, discontinuation or decreased doses of immunosuppressive therapy also may be warranted [
         <a href="#rid1">
          1
         </a>
         ]. Given the lack of high-quality evidence for treatment of HHV-6 infection, consultation with an expert in pediatric infectious diseases is suggested.
        </p>
        <p>
         Supportive care and long-term follow-up for children with encephalitis and treatment of HHV-6 encephalitis in hematopoietic cell recipients are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5977.html" rel="external">
          "Acute viral encephalitis in children: Treatment and prevention"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16146.html" rel="external">
          "Human herpesvirus 6 infection in hematopoietic cell transplant recipients", section on 'Antiviral selection'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4181216161">
         <span class="h2">
          Choice of therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         When treatment of HHV-6 infection is necessary,
         <a class="drug drug_pediatric" data-topicid="13331" href="/z/d/drug information/13331.html" rel="external">
          ganciclovir
         </a>
         or
         <a class="drug drug_pediatric" data-topicid="13325" href="/z/d/drug information/13325.html" rel="external">
          foscarnet
         </a>
         generally is preferred to
         <a class="drug drug_pediatric" data-topicid="13155" href="/z/d/drug information/13155.html" rel="external">
          cidofovir
         </a>
         [
         <a href="#rid1">
          1
         </a>
         ], because cidofovir is nephrotoxic [
         <a href="#rid123">
          123
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8288.html" rel="external">
          "Foscarnet: An overview"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8342.html" rel="external">
          "Ganciclovir and valganciclovir: An overview"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8297.html" rel="external">
          "Cidofovir: An overview"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Controlled trials of antiviral therapy for HHV-6 infection are lacking. In vitro, HHV-6 is susceptible to
         <a class="drug drug_pediatric" data-topicid="13325" href="/z/d/drug information/13325.html" rel="external">
          foscarnet
         </a>
         ,
         <a class="drug drug_pediatric" data-topicid="13331" href="/z/d/drug information/13331.html" rel="external">
          ganciclovir
         </a>
         , and
         <a class="drug drug_pediatric" data-topicid="13155" href="/z/d/drug information/13155.html" rel="external">
          cidofovir
         </a>
         [
         <a href="#rid124">
          124
         </a>
         ]. Foscarnet and cidofovir are active against both HHV-6A and HHV-6B [
         <a href="#rid124">
          124
         </a>
         ]. Ganciclovir is active against HHV-6B, but in some reports HHV-6A was relatively resistant [
         <a href="#rid125">
          125-127
         </a>
         ].
        </p>
        <p>
         Several case reports and case series have suggested improvement in presumed HHV-6 encephalitis after administration
         <a class="drug drug_pediatric" data-topicid="13325" href="/z/d/drug information/13325.html" rel="external">
          foscarnet
         </a>
         or
         <a class="drug drug_pediatric" data-topicid="13331" href="/z/d/drug information/13331.html" rel="external">
          ganciclovir
         </a>
         [
         <a href="#rid128">
          128-132
         </a>
         ]. However, in a small case series of HHV-6 encephalitis in immunocompetent children, neurologic symptoms did not improve with ganciclovir therapy [
         <a href="#rid35">
          35
         </a>
         ]. In another retrospective study, ganciclovir prophylaxis in children receiving hematopoietic cell transplant was associated with a decrease in HHV-6 reactivation and HHV-6 viral load [
         <a href="#rid133">
          133
         </a>
         ]. These findings require confirmation in controlled trials.
        </p>
        <p class="headingAnchor" id="H30387434">
         <span class="h2">
          Response to therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Response to therapy is determined by improvement in clinical symptoms and decreased viral load (if viral load was measured at diagnosis) [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Clinical improvement without decrease in viral load or decrease in viral load without clinical improvement may indicate that HHV-6 was not the causative agent. Lack of improvement may indicate the emergence of resistance and susceptibility testing may be warranted [
         <a href="#rid134">
          134,135
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6690627">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword[s] of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/17204.html" rel="external">
          "Patient education: Roseola (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology –
         </strong>
         Human herpesvirus 6 (HHV-6) infects most children within the first two years of life. In developed countries, the rate of seroprevalence among adults is &gt;70 percent. Transmission occurs mainly through saliva. (See
         <a class="local">
          'Epidemiology and transmission'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The clinical presentations of HHV-6 infection vary with the age and immune-competence of the child.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The incubation period ranges from 5 to 15 days. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The classic manifestations of primary HHV-6 infection in immunocompetent children are acute febrile illnesses with or without a rash and roseola infantum  (
         <a class="graphic graphic_picture graphicRef81967" href="/z/d/graphic/81967.html" rel="external">
          picture 1
         </a>
         ) (also known as exanthem subitum and sixth disease). (See
         <a class="local">
          'Acute febrile illness'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/6035.html" rel="external">
          "Roseola infantum (exanthem subitum)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Associated syndromes
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         HHV-6 has been reported in association with a variety of other clinical syndromes (eg, hepatitis, myocarditis). However, HHV-6 may be activated by a number of acute illnesses, and it is difficult to establish HHV-6 as the causative agent. (See
         <a class="local">
          'Less common manifestations'
         </a>
         above and
         <a class="local">
          'Unproven associations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Reactivation of HHV-6 may be associated with clinically relevant clinical syndromes (eg, encephalitis, pneumonitis) in immunocompromised children, including hematopoietic cell or solid organ transplant recipients. (See
         <a class="local">
          'Immunocompromised children'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In immunocompetent children with typical presentations of HHV-6 (eg, acute illness with high fever, with or without rash, and nonspecific symptoms), laboratory confirmation of HHV-6 is seldom necessary and is unlikely to affect management. (See
         <a class="local">
          'In immunocompetent children'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Laboratory identification of HHV-6 may be necessary in immunocompromised children or immunocompetent children with atypical presentations or complications (eg, meningoencephalitis). (See
         <a class="local">
          'Indications for laboratory confirmation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Confirmation that an illness is caused by HHV-6 typically requires a compatible clinical syndrome, evidence of active HHV-6 infection (ie, with viral replication), and elimination of other conditions in the differential diagnosis. A combination of laboratory tests may be necessary  (
         <a class="graphic graphic_table graphicRef83219" href="/z/d/graphic/83219.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Approach to laboratory testing'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis –
         </strong>
         The differential diagnosis of HHV-6 infection includes other causes or mimics of acute febrile illness, fever and rash  (
         <a class="graphic graphic_figure graphicRef104587" href="/z/d/graphic/104587.html" rel="external">
          figure 2
         </a>
         ), febrile seizures, and meningoencephalitis. (See
         <a class="medical medical_review" href="/z/d/html/6075.html" rel="external">
          "Fever without a source in children 3 to 36 months of age: Evaluation and management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6035.html" rel="external">
          "Roseola infantum (exanthem subitum)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6183.html" rel="external">
          "Clinical features and evaluation of febrile seizures"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6042.html" rel="external">
          "Acute viral encephalitis in children: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment –
         </strong>
         HHV-6 infection is usually self-limited and does not warrant specific therapy. Antiviral therapy may be warranted for HHV-6 infections associated with increased morbidity (eg, encephalitis, myocarditis) in both immunocompetent and immunocompromised hosts; consultation with an expert in pediatric infectious diseases is suggested. (See
         <a class="local">
          'Treatment'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Agut H, Bonnafous P, Gautheret-Dejean A. Laboratory and clinical aspects of human herpesvirus 6 infections. Clin Microbiol Rev 2015; 28:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pellett PE, Ablashi DV, Ambros PF, et al. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol 2012; 22:144.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hall CB, Caserta MT, Schnabel K, et al. Chromosomal integration of human herpesvirus 6 is the major mode of congenital human herpesvirus 6 infection. Pediatrics 2008; 122:513.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005; 352:768.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hall CB, Long CE, Schnabel KC, et al. Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 1994; 331:432.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akashi K, Eizuru Y, Sumiyoshi Y, et al. Brief report: severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult. N Engl J Med 1993; 329:168.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hall CB, Caserta MT. Exanthem subitum (Roseola infantum). Herpes 1999; 6:64.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Human herpesvirus 6 (including roseola) and 7. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.422.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hall CB, Caserta MT, Schnabel KC, et al. Transplacental congenital human herpesvirus 6 infection caused by maternal chromosomally integrated virus. J Infect Dis 2010; 201:505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kusuhara K, Takabayashi A, Ueda K, et al. Breast milk is not a significant source for early Epstein-Barr virus or human herpesvirus 6 infection in infants: a seroepidemiologic study in 2 endemic areas of human T-cell lymphotropic virus type I in Japan. Microbiol Immunol 1997; 41:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lau YL, Peiris M, Chan GC, et al. Primary human herpes virus 6 infection transmitted from donor to recipient through bone marrow infusion. Bone Marrow Transplant 1998; 21:1063.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ward KN, Gray JJ, Efstathiou S. Brief report: primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donor. J Med Virol 1989; 28:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muramatsu H, Watanabe N, Matsumoto K, et al. Primary infection of human herpesvirus-6 in an infant who received cord blood SCT. Bone Marrow Transplant 2009; 43:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pilmore H, Collins J, Dittmer I, et al. Fatal human herpesvirus-6 infection after renal transplantation. Transplantation 2009; 88:762.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leong HN, Tuke PW, Tedder RS, et al. The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors. J Med Virol 2007; 79:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daibata M, Taguchi T, Nemoto Y, et al. Inheritance of chromosomally integrated human herpesvirus 6 DNA. Blood 1999; 94:1545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clark DA, Nacheva EP, Leong HN, et al. Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis. J Infect Dis 2006; 193:912.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strenger V, Urban C, Schwinger W, et al. Transmission of chromosomally integrated HHV-6 by bone marrow transplantation. Pediatr Blood Cancer 2011; 56:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hall CB, Caserta MT, Schnabel KC, et al. Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7). J Pediatr 2004; 145:472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adams O, Krempe C, Kögler G, et al. Congenital infections with human herpesvirus 6. J Infect Dis 1998; 178:544.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caserta MT, Hall CB, Canfield RL, et al. Early developmental outcomes of children with congenital HHV-6 infection. Pediatrics 2014; 134:1111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rentz AC, Stevenson J, Hymas W, et al. Human herpesvirus 6 in the newborn intensive care unit. Eur J Clin Microbiol Infect Dis 2007; 26:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Irving WL, Chang J, Raymond DR, et al. Roseola infantum and other syndromes associated with acute HHV6 infection. Arch Dis Child 1990; 65:1297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rohayem J, Dinger J, Fischer R, et al. Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection. J Clin Microbiol 2001; 39:4585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pruksananonda P, Hall CB, Insel RA, et al. Primary human herpesvirus 6 infection in young children. N Engl J Med 1992; 326:1445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suga S, Yoshikawa T, Asano Y, et al. Human herpesvirus-6 infection (exanthem subitum) without rash. Pediatrics 1989; 83:1003.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freitas RB, Monteiro TA, Linhares AC. Outbreaks of human-herpes virus 6 (HHV-6) infection in day-care centers in Belém, Pará, Brazil. Rev Inst Med Trop Sao Paulo 2000; 42:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zerr DM, Frenkel LM, Huang ML, et al. Polymerase chain reaction diagnosis of primary human herpesvirus-6 infection in the acute care setting. J Pediatr 2006; 149:480.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ward KN, Andrews NJ, Verity CM, et al. Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland. Arch Dis Child 2005; 90:619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suga S, Suzuki K, Ihira M, et al. Clinical characteristics of febrile convulsions during primary HHV-6 infection. Arch Dis Child 2000; 82:62.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hattori F, Kawamura Y, Kozawa K, et al. Clinical Characteristics of Primary HHV-6B Infection in Children Visiting the Emergency Room. Pediatr Infect Dis J 2019; 38:e248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vianna RA, de Oliveira SA, Camacho LA, et al. Role of human herpesvirus 6 infection in young Brazilian children with rash illnesses. Pediatr Infect Dis J 2008; 27:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ohsaka M, Houkin K, Takigami M, Koyanagi I. Acute necrotizing encephalopathy associated with human herpesvirus-6 infection. Pediatr Neurol 2006; 34:160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mannonen L, Herrgård E, Valmari P, et al. Primary human herpesvirus-6 infection in the central nervous system can cause severe disease. Pediatr Neurol 2007; 37:186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crawford JR, Kadom N, Santi MR, et al. Human herpesvirus 6 rhombencephalitis in immunocompetent children. J Child Neurol 2007; 22:1260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Provenzale JM, van Landingham K, White LE. Clinical and imaging findings suggesting human herpesvirus 6 encephalitis. Pediatr Neurol 2010; 42:32.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Isaacson E, Glaser CA, Forghani B, et al. Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis. Clin Infect Dis 2005; 40:890.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           You SJ. Human Herpesvirus-6 may be Neurologically Injurious in Some Immunocompetent Children. J Child Neurol 2020; 35:132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matsumoto K, Kato A, Inagi R, et al. Herpesvirus-6 (HHV-6) encephalitis in a child presenting as a focal necrotic lesion. Acta Neurochir (Wien) 1999; 141:439.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kawabe S, Ito Y, Ohta R, et al. Comparison of the levels of human herpesvirus 6 (HHV-6) DNA and cytokines in the cerebrospinal fluid and serum of children with HHV-6 encephalopathy. J Med Virol 2010; 82:1410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fotheringham J, Donati D, Akhyani N, et al. Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Med 2007; 4:e180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Donati D, Akhyani N, Fogdell-Hahn A, et al. Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology 2003; 61:1405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kawamura Y, Nakayama A, Kato T, et al. Pathogenic Role of Human Herpesvirus 6B Infection in Mesial Temporal Lobe Epilepsy. J Infect Dis 2015; 212:1014.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanegane C, Katayama K, Kyoutani S, et al. Mononucleosis-like illness in an infant associated with human herpesvirus 6 infection. Acta Paediatr Jpn 1995; 37:227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Niederman JC, Liu CR, Kaplan MH, Brown NA. Clinical and serological features of human herpesvirus-6 infection in three adults. Lancet 1988; 2:817.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maric I, Bryant R, Abu-Asab M, et al. Human herpesvirus-6-associated acute lymphadenitis in immunocompetent adults. Mod Pathol 2004; 17:1427.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang CH, Sahoo MK, Fitzpatrick M, et al. Evaluating for Human Herpesvirus 6 in the Liver Explants of Children With Liver Failure of Unknown Etiology. J Infect Dis 2019; 220:361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Szewc AM, Taylor S, Cage GD, et al. Acute Liver Failure in an Adolescent Male Induced by Human Herpesvirus 6 (HHV-6): A Case Report With Literature Review. Lab Med 2018; 49:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hammerling JA, Lambrecht RS, Kehl KS, Carrigan DR. Prevalence of human herpesvirus 6 in lung tissue from children with pneumonitis. J Clin Pathol 1996; 49:802.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yoshikawa T, Ihira M, Suzuki K, et al. Fatal acute myocarditis in an infant with human herpesvirus 6 infection. J Clin Pathol 2001; 54:792.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahrholdt H, Wagner A, Deluigi CC, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006; 114:1581.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Comar M, D'Agaro P, Campello C, et al. Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease. J Clin Pathol 2009; 62:80.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Das BB. A Neonate with Acute Heart Failure: Chromosomally Integrated Human Herpesvirus 6-Associated Dilated Cardiomyopathy. J Pediatr 2015; 167:188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reddy S, Eliassen E, Krueger GR, Das BB. Human herpesvirus 6-induced inflammatory cardiomyopathy in immunocompetent children. Ann Pediatr Cardiol 2017; 10:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saijo M, Saijo H, Yamamoto M, et al. Thrombocytopenic purpura associated with primary human herpesvirus 6 infection. Pediatr Infect Dis J 1995; 14:405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishimura K, Igarashi M. Thrombocytopenic purpura associated with exanthema subitum. Pediatrics 1977; 60:260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Portolani M, Cermelli C, Meacci M, et al. Primary infection by HHV-6 variant B associated with a fatal case of hemophagocytic syndrome. New Microbiol 1997; 20:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang LM, Lee CY, Lin KH, et al. Human herpesvirus-6 associated with fatal haemophagocytic syndrome. Lancet 1990; 336:60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takagi M, Unno A, Maruyama T, et al. Human herpesvirus-6 (HHV-6)-associated hemophagocytic syndrome. Pediatr Hematol Oncol 1996; 13:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glotzbecker MP, Carpentieri DF, Dormans JP. Langerhans cell histiocytosis: a primary viral infection of bone? Human herpes virus 6 latent protein detected in lymphocytes from tissue of children. J Pediatr Orthop 2004; 24:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fretzayas A, Douros K, Moustaki M, Nicolaidou P. Papular-purpuric gloves and socks syndrome in children and adolescents. Pediatr Infect Dis J 2009; 28:250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chuh AA, Chan HH, Chiu SS, et al. A prospective case control study of the association of Gianotti-Crosti syndrome with human herpesvirus 6 and human herpesvirus 7 infections. Pediatr Dermatol 2002; 19:492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boccara O, Lesage F, Regnault V, et al. Nonbacterial purpura fulminans and severe autoimmune acquired protein S deficiency associated with human herpesvirus-6 active replication. Br J Dermatol 2009; 161:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miyake F, Yoshikawa T, Suzuki K, et al. Guillain-Barré syndrome after exanthem subitum. Pediatr Infect Dis J 2002; 21:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pitkäranta A, Lahdenne P, Piiparinen H. Facial nerve palsy after human herpesvirus 6 infection. Pediatr Infect Dis J 2004; 23:688.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Genizi J, Golan-Shany O, Tarazov T, et al. Does Herpes 6 Infection Have a Role in Bell's Palsy Among Children and Adolescents? Pediatr Infect Dis J 2019; 38:481.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olson CA, Dominguez SR, Miller S, et al. Gastroenteritis, Hepatitis, Encephalopathy, and Human Herpesvirus 6 Detection in an Immunocompetent Child: Benefits and Risks of Syndromic Multiplex Molecular Panel Testing. J Pediatr 2019; 212:228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vuorinen T, Kotilainen P, Lautenschlager I, et al. Interstitial pneumonitis and coinfection of human herpesvirus 6 and Pneumocystis carinii in a patient with hypogammaglobulinemia. J Clin Microbiol 2004; 42:5415.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loutfy SA, Fawzy M, El-Wakil M, Moneer MM. Presence of human herpes virus 6 (HHV6) in pediatric lymphomas: impact on clinical course and association with cytomegalovirus infection. Virol J 2010; 7:287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yee-Guardino S, Gowans K, Yen-Lieberman B, et al. Beta-herpesviruses in febrile children with cancer. Emerg Infect Dis 2008; 14:579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dockrell DH, Paya CV. Human herpesvirus-6 and -7 in transplantation. Rev Med Virol 2001; 11:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yoshikawa T. Human herpesvirus-6 and -7 infections in transplantation. Pediatr Transplant 2003; 7:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pappo-Toledano A, Dovrat S, Soufiev Z, et al. Primary infection with human herpes virus type 6, post-pediatric liver transplantation-A pathogen to remember. Transpl Infect Dis 2019; 21:e13014.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ylinen E, Lehtinen S, Jahnukainen T, et al. Human herpes virus 6 infection in pediatric organ transplant patients. Pediatr Transplant 2017; 21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mysore KR, Phan TL, Himes RW, et al. Human Herpesvirus 6 Infection in Pediatric Liver Transplantation: Single-Center Study of Incidence, Outcomes, and Management. J Pediatric Infect Dis Soc 2021; 10:599.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yoshikawa T, Asano Y, Ihira M, et al. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis 2002; 185:847.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Buchbinder S, Elmaagacli AH, Schaefer UW, Roggendorf M. Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 2000; 26:639.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yoshikawa T, Ihira M, Furukawa H, et al. Four cases of human herpesvirus 6 variant B infection after pediatric liver transplantation. Transplantation 1998; 65:1266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yoshikawa T, Ihira M, Suzuki K, et al. Human herpesvirus 6 infection after living related liver transplantation. J Med Virol 2000; 62:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asano Y, Yoshikawa T, Suga S, et al. Reactivation of herpesvirus type 6 in children receiving bone marrow transplants for leukemia. N Engl J Med 1991; 324:634.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cone RW, Hackman RC, Huang ML, et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 1993; 329:156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knox KK, Pietryga D, Harrington DJ, et al. Progressive immunodeficiency and fatal pneumonitis associated with human herpesvirus 6 infection in an infant. Clin Infect Dis 1995; 20:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stefanski HE, Thibert KA, Pritchett J, et al. Fatal Myocarditis Associated With HHV-6 Following Immunosuppression in Two Children. Pediatrics 2016; 137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allen UD, Tellier R, Doyle J, et al. The utility of plasma polymerase chain reaction for human herpes virus-6 among pediatric bone marrow transplant recipients: results of a pilot study. Bone Marrow Transplant 2001; 28:473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh N, Paterson DL. Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus. Transplantation 2000; 69:2474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nash PJ, Avery RK, Tang WH, et al. Encephalitis owing to human herpesvirus-6 after cardiac transplant. Am J Transplant 2004; 4:1200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miura H, Kawamura Y, Hattori F, et al. Human herpesvirus-6B infection in pediatric allogenic hematopoietic stem cell transplant patients: Risk factors and encephalitis. Transpl Infect Dis 2020; 22:e13203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delbridge MS, Karim MS, Shrestha BM, McKane W. Colitis in a renal transplant patient with human herpesvirus-6 infection. Transpl Infect Dis 2006; 8:226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drobyski WR, Dunne WM, Burd EM, et al. Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo. J Infect Dis 1993; 167:735.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang FZ, Linde A, Dahl H, Ljungman P. Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation. Bone Marrow Transplant 1999; 24:1201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lecointe D, Fabre M, Habes D, et al. [Macrophage activation syndrome in primary human herpes virus-6 infection: a rare condition after liver transplantation in infants]. Gastroenterol Clin Biol 2000; 24:1227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Volin L, Lautenschlager I, Juvonen E, et al. Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses. Br J Haematol 2004; 126:690.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang FZ, Dahl H, Linde A, et al. Lymphotropic herpesviruses in allogeneic bone marrow transplantation. Blood 1996; 88:3615.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zerr DM, Boeckh M, Delaney C, et al. HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012; 18:1700.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dulery R, Salleron J, Dewilde A, et al. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study. Biol Blood Marrow Transplant 2012; 18:1080.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caserta MT, McDermott MP, Dewhurst S, et al. Human herpesvirus 6 (HHV6) DNA persistence and reactivation in healthy children. J Pediatr 2004; 145:478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Green DA, Pereira M, Miko B, et al. Clinical Significance of Human Herpesvirus 6 Positivity on the FilmArray Meningitis/Encephalitis Panel. Clin Infect Dis 2018; 67:1125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slenker AK, Royer TL, Villalobos T. Human Herpesvirus 6 Positivity on the FilmArray Meningitis/Encephalitis Panel Needs Clinical Interpretation. Clin Infect Dis 2019; 69:192.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kainth MK, Caserta MT. Molecular diagnostic tests for human herpesvirus 6. Pediatr Infect Dis J 2011; 30:604.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caserta MT, Hall CB, Schnabel K, et al. Diagnostic assays for active infection with human herpesvirus 6 (HHV-6). J Clin Virol 2010; 48:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ongrádi J, Ablashi DV, Yoshikawa T, et al. Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals. J Neurovirol 2017; 23:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fotheringham J, Akhyani N, Vortmeyer A, et al. Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid. J Infect Dis 2007; 195:450.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Canto CL, Sumita LM, Machado AF, et al. Optimization of the Sybr Green real time PCR for the detection of Human Herpes Virus type 6 (HHV-6). Rev Inst Med Trop Sao Paulo 2008; 50:61.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deback C, Agbalika F, Scieux C, et al. Detection of human herpesviruses HHV-6, HHV-7 and HHV-8 in whole blood by real-time PCR using the new CMV, HHV-6, 7, 8 R-gene kit. J Virol Methods 2008; 149:285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Engelmann I, Petzold DR, Kosinska A, et al. Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens. J Med Virol 2008; 80:467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flamand L, Gravel A, Boutolleau D, et al. Multicenter comparison of PCR assays for detection of human herpesvirus 6 DNA in serum. J Clin Microbiol 2008; 46:2700.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liesman RM, Strasburg AP, Heitman AK, et al. Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis. J Clin Microbiol 2018; 56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sedlak RH, Cook L, Huang ML, et al. Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR. Clin Chem 2014; 60:765.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Norton RA, Caserta MT, Hall CB, et al. Detection of human herpesvirus 6 by reverse transcription-PCR. J Clin Microbiol 1999; 37:3672.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fujiwara N, Namba H, Ohuchi R, et al. Monitoring of human herpesvirus-6 and -7 genomes in saliva samples of healthy adults by competitive quantitative PCR. J Med Virol 2000; 61:208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blumberg BM, Mock DJ, Powers JM, et al. The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach. J Clin Virol 2000; 16:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ihira M, Ohta A, Sugata K, et al. Loop-mediated isothermal amplification for discriminating between human herpesvirus 6 A and B. J Virol Methods 2008; 154:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pandey U, Greninger AL, Levin GR, et al. Pathogen or Bystander: Clinical Significance of Detecting Human Herpesvirus 6 in Pediatric Cerebrospinal Fluid. J Clin Microbiol 2020; 58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishimura N, Yoshikawa T, Ozaki T, et al. In vitro and in vivo analysis of human herpesvirus-6 U90 protein expression. J Med Virol 2005; 75:86.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lautenschlager I, Höckerstedt K, Linnavuori K, Taskinen E. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 1998; 26:702.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loginov R, Karlsson T, Höckerstedt K, et al. Quantitative HHV-6B antigenemia test for the monitoring of transplant patients. Eur J Clin Microbiol Infect Dis 2010; 29:881.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Couillard M, Joly JR, Deschênes L, Richer G. Evaluation of variables in immunofluorescence procedures for the detection of antibodies against human herpesvirus 6 (HHV-6). Diagn Microbiol Infect Dis 1992; 15:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robert C, Agut H, Aubin JT, et al. Detection of antibodies to human herpesvirus-6 using immunofluorescence assay. Res Virol 1990; 141:545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chou SW, Scott KM. Rises in antibody to human herpesvirus 6 detected by enzyme immunoassay in transplant recipients with primary cytomegalovirus infection. J Clin Microbiol 1990; 28:851.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Linnavuori K, Peltola H, Hovi T. Serology versus clinical signs or symptoms and main laboratory findings in the diagnosis of exanthema subitum (roseola infantum). Pediatrics 1992; 89:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suga S, Yoshikawa T, Asano Y, et al. IgM neutralizing antibody responses to human herpesvirus-6 in patients with exanthem subitum or organ transplantation. Microbiol Immunol 1992; 36:495.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nielsen L, Vestergaard BF. A mu-capture immunoassay for detection of human herpes virus-6 (HHV-6) IgM antibodies in human serum. J Clin Virol 2002; 25:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dewhurst S. Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes 2004; 11 Suppl 2:105A.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prichard MN, Whitley RJ. The development of new therapies for human herpesvirus 6. Curr Opin Virol 2014; 9:148.
          </a>
         </li>
         <li class="breakAll">
          Williams MV. HHV-6: response to antiviral agents. In: Human Herpesvirus-6: Epidemiology, Molecular Biology, and Clinical Pathology, Ablashi DV, Krueger RF, Salahuddin SZ (Eds), Elsevier Biomedical Press, Amsterdam 1992. p.317.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manichanh C, Olivier-Aubron C, Lagarde JP, et al. Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo. J Gen Virol 2001; 82:2767.
          </a>
         </li>
         <li class="breakAll">
          Williams MV. HHV-6: response to antiviral agents. In: Human herpesvirus-6: epidemiology, molecular biology, and clinical pathology, Ablashi DV, Krueger RF, Salahuddin SZ (Eds), Elsevier Biomedical Press, Amsterdam  p.317.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Denes E, Magy L, Pradeau K, et al. Successful treatment of human herpesvirus 6 encephalomyelitis in immunocompetent patient. Emerg Infect Dis 2004; 10:729.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zerr DM, Gupta D, Huang ML, et al. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sadighi Z, Sabin ND, Hayden R, et al. Diagnostic Clues to Human Herpesvirus 6 Encephalitis and Wernicke Encephalopathy After Pediatric Hematopoietic Cell Transplantation. J Child Neurol 2015; 30:1307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pöhlmann C, Schetelig J, Reuner U, et al. Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient. Clin Infect Dis 2007; 44:e118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olli-Lähdesmäki T, Haataja L, Parkkola R, et al. High-dose ganciclovir in HHV-6 encephalitis of an immunocompetent child. Pediatr Neurol 2010; 43:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tokimasa S, Hara J, Osugi Y, et al. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant 2002; 29:595.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Piret J, Boivin G. Antiviral drug resistance in herpesviruses other than cytomegalovirus. Rev Med Virol 2014; 24:186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Isegawa Y, Hara J, Amo K, et al. Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient. J Clin Virol 2009; 44:15.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5969 Version 23.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25762531" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Laboratory and clinical aspects of human herpesvirus 6 infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22052666" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Chromosomally integrated human herpesvirus 6: questions and answers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18762520" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Chromosomal integration of human herpesvirus 6 is the major mode of congenital human herpesvirus 6 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15728809" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : A population-based study of primary human herpesvirus 6 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8035839" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Human herpesvirus-6 infection in children. A prospective study of complications and reactivation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8390615" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Brief report: severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Exanthem subitum (Roseola infantum)
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Exanthem subitum (Roseola infantum)
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20088693" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Transplacental congenital human herpesvirus 6 infection caused by maternal chromosomally integrated virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9159404" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Breast milk is not a significant source for early Epstein-Barr virus or human herpesvirus 6 infection in infants: a seroepidemiologic study in 2 endemic areas of human T-cell lymphotropic virus type I in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9632282" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Primary human herpes virus 6 infection transmitted from donor to recipient through bone marrow infusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2544678" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Brief report: primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18762769" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Primary infection of human herpesvirus-6 in an infant who received cord blood SCT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19920774" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Fatal human herpesvirus-6 infection after renal transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17133548" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10477678" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Inheritance of chromosomally integrated human herpesvirus 6 DNA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16518751" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21064150" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Transmission of chromosomally integrated HHV-6 by bone marrow transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15480369" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9697740" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Congenital infections with human herpesvirus 6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25367540" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Early developmental outcomes of children with congenital HHV-6 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17364195" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Human herpesvirus 6 in the newborn intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2176778" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Roseola infantum and other syndromes associated with acute HHV6 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11724892" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Fatal myocarditis associated with acute parvovirus B19 and human herpesvirus 6 coinfection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1315416" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Primary human herpesvirus 6 infection in young children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2542875" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Human herpesvirus-6 infection (exanthem subitum) without rash.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11136516" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Outbreaks of human-herpes virus 6 (HHV-6) infection in day-care centers in Belém, Pará, Brazil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17011318" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Polymerase chain reaction diagnosis of primary human herpesvirus-6 infection in the acute care setting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15908629" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Human herpesviruses-6 and -7 each cause significant neurological morbidity in Britain and Ireland.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10630916" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Clinical characteristics of febrile convulsions during primary HHV-6 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31261358" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Clinical Characteristics of Primary HHV-6B Infection in Children Visiting the Emergency Room.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18449066" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Role of human herpesvirus 6 infection in young Brazilian children with rash illnesses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16458833" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Acute necrotizing encephalopathy associated with human herpesvirus-6 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17765806" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Primary human herpesvirus-6 infection in the central nervous system can cause severe disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18006954" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Human herpesvirus 6 rhombencephalitis in immunocompetent children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20004860" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Clinical and imaging findings suggesting human herpesvirus 6 encephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15736026" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31635508" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Human Herpesvirus-6 may be Neurologically Injurious in Some Immunocompetent Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10352757" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Herpesvirus-6 (HHV-6) encephalitis in a child presenting as a focal necrotic lesion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20572074" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Comparison of the levels of human herpesvirus 6 (HHV-6) DNA and cytokines in the cerebrospinal fluid and serum of children with HHV-6 encephalopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17535102" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Association of human herpesvirus-6B with mesial temporal lobe epilepsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14638964" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25840441" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Pathogenic Role of Human Herpesvirus 6B Infection in Mesial Temporal Lobe Epilepsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7793262" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Mononucleosis-like illness in an infant associated with human herpesvirus 6 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2902266" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Clinical and serological features of human herpesvirus-6 infection in three adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15494709" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Human herpesvirus-6-associated acute lymphadenitis in immunocompetent adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30418598" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Evaluating for Human Herpesvirus 6 in the Liver Explants of Children With Liver Failure of Unknown Etiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29390152" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Acute Liver Failure in an Adolescent Male Induced by Human Herpesvirus 6 (HHV-6): A Case Report With Literature Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8943744" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Prevalence of human herpesvirus 6 in lung tissue from children with pneumonitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11577130" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Fatal acute myocarditis in an infant with human herpesvirus 6 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17015795" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Presentation, patterns of myocardial damage, and clinical course of viral myocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18818265" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25863663" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : A Neonate with Acute Heart Failure: Chromosomally Integrated Human Herpesvirus 6-Associated Dilated Cardiomyopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28928612" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Human herpesvirus 6-induced inflammatory cardiomyopathy in immunocompetent children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7638026" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Thrombocytopenic purpura associated with primary human herpesvirus 6 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/887348" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Thrombocytopenic purpura associated with exanthema subitum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9037663" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Primary infection by HHV-6 variant B associated with a fatal case of hemophagocytic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1973248" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Human herpesvirus-6 associated with fatal haemophagocytic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10897817" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Human herpesvirus-6 (HHV-6)-associated hemophagocytic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14676546" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Langerhans cell histiocytosis: a primary viral infection of bone? Human herpes virus 6 latent protein detected in lymphocytes from tissue of children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19165131" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Papular-purpuric gloves and socks syndrome in children and adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12437548" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : A prospective case control study of the association of Gianotti-Crosti syndrome with human herpesvirus 6 and human herpesvirus 7 infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19545295" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Nonbacterial purpura fulminans and severe autoimmune acquired protein S deficiency associated with human herpesvirus-6 active replication.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12182386" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Guillain-Barrésyndrome after exanthem subitum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15247617" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Facial nerve palsy after human herpesvirus 6 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30724837" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Does Herpes 6 Infection Have a Role in Bell's Palsy Among Children and Adolescents?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31208781" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Gastroenteritis, Hepatitis, Encephalopathy, and Human Herpesvirus 6 Detection in an Immunocompetent Child: Benefits and Risks of Syndromic Multiplex Molecular Panel Testing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15528760" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Interstitial pneumonitis and coinfection of human herpesvirus 6 and Pneumocystis carinii in a patient with hypogammaglobulinemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20979645" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Presence of human herpes virus 6 (HHV6) in pediatric lymphomas: impact on clinical course and association with cytomegalovirus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18394275" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Beta-herpesviruses in febrile children with cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11241800" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Human herpesvirus-6 and -7 in transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12581322" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Human herpesvirus-6 and -7 infections in transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30346638" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Primary infection with human herpes virus type 6, post-pediatric liver transplantation-A pathogen to remember.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28213954" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Human herpes virus 6 infection in pediatric organ transplant patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33491073" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Human Herpesvirus 6 Infection in Pediatric Liver Transplantation: Single-Center Study of Incidence, Outcomes, and Management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11920307" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11035370" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9603179" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Four cases of human herpesvirus 6 variant B infection after pediatric liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10935989" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Human herpesvirus 6 infection after living related liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1846942" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Reactivation of herpesvirus type 6 in children receiving bone marrow transplants for leukemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8390614" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7742449" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Progressive immunodeficiency and fatal pneumonitis associated with human herpesvirus 6 infection in an infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26681781" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Fatal Myocarditis Associated With HHV-6 Following Immunosuppression in Two Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11593320" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : The utility of plasma polymerase chain reaction for human herpes virus-6 among pediatric bone marrow transplant recipients: results of a pilot study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10910264" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15196083" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Encephalitis owing to human herpesvirus-6 after cardiac transplant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31650671" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Human herpesvirus-6B infection in pediatric allogenic hematopoietic stem cell transplant patients: Risk factors and encephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17116137" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Colitis in a renal transplant patient with human herpesvirus-6 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8382723" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10642809" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11173737" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : [Macrophage activation syndrome in primary human herpes virus-6 infection: a rare condition after liver transplantation in infants].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15327521" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other beta-herpesviruses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8896431" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Lymphotropic herpesviruses in allogeneic bone marrow transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22641196" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22212513" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15480370" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Human herpesvirus 6 (HHV6) DNA persistence and reactivation in healthy children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29635334" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Clinical Significance of Human Herpesvirus 6 Positivity on the FilmArray Meningitis/Encephalitis Panel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30689806" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Human Herpesvirus 6 Positivity on the FilmArray Meningitis/Encephalitis Panel Needs Clinical Interpretation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21673548" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Molecular diagnostic tests for human herpesvirus 6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20211581" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Diagnostic assays for active infection with human herpesvirus 6 (HHV-6).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27538995" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17205485" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18327491" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Optimization of the Sybr Green real time PCR for the detection of Human Herpes Virus type 6 (HHV-6).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18329730" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Detection of human herpesviruses HHV-6, HHV-7 and HHV-8 in whole blood by real-time PCR using the new CMV, HHV-6, 7, 8 R-gene kit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18205230" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18550745" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Multicenter comparison of PCR assays for detection of human herpesvirus 6 DNA in serum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29436421" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Evaluation of a Commercial Multiplex Molecular Panel for Diagnosis of Infectious Meningitis and Encephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24594780" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10523572" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Detection of human herpesvirus 6 by reverse transcription-PCR.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10797376" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Monitoring of human herpesvirus-6 and -7 genomes in saliva samples of healthy adults by competitive quantitative PCR.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10738136" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : The HHV6 paradox: ubiquitous commensal or insidious pathogen? A two-step in situ PCR approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18706448" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Loop-mediated isothermal amplification for discriminating between human herpesvirus 6 A and B.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32102858" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Pathogen or Bystander: Clinical Significance of Detecting Human Herpesvirus 6 in Pediatric Cerebrospinal Fluid.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15543572" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : In vitro and in vivo analysis of human herpesvirus-6 U90 protein expression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9524848" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Human herpesvirus-6 infection after liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20407819" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Quantitative HHV-6B antigenemia test for the monitoring of transplant patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1319300" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Evaluation of variables in immunofluorescence procedures for the detection of antibodies against human herpesvirus 6 (HHV-6).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2177566" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Detection of antibodies to human herpesvirus-6 using immunofluorescence assay.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2161867" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Rises in antibody to human herpesvirus 6 detected by enzyme immunoassay in transplant recipients with primary cytomegalovirus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1309393" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Serology versus clinical signs or symptoms and main laboratory findings in the diagnosis of exanthema subitum (roseola infantum).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1325026" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : IgM neutralizing antibody responses to human herpesvirus-6 in patients with exanthem subitum or organ transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12367648" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : A mu-capture immunoassay for detection of human herpes virus-6 (HHV-6) IgM antibodies in human serum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15319097" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25462447" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : The development of new therapies for human herpesvirus 6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25462447" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : The development of new therapies for human herpesvirus 6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11602788" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11602788" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Selection of the same mutation in the U69 protein kinase gene of human herpesvirus-6 after prolonged exposure to ganciclovir in vitro and in vivo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15200871" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Successful treatment of human herpesvirus 6 encephalomyelitis in immunocompetent patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11774077" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25564483" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Diagnostic Clues to Human Herpesvirus 6 Encephalitis and Wernicke Encephalopathy After Pediatric Hematopoietic Cell Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17516391" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20682205" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : High-dose ganciclovir in HHV-6 encephalitis of an immunocompetent child.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11979309" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24604770" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : Antiviral drug resistance in herpesviruses other than cytomegalovirus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18952495" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
